Professional Documents
Culture Documents
DX & MX of Limb Ischemia New
DX & MX of Limb Ischemia New
THIS IS AN EMERGENCY !
• Complete arterial occlusion will lead to irreversible limb damage within 6 hours.
REMEMBER THE 6PS!
1. PAIN
2. PALLOR
3. PULSELESSNESS
4. PERISHING COLD (POIKILOTHERMIA)
5. PARASTHESIAS
6. PARALYSIS
CAUSES
• TRAUMATIC :
•NON TRAUMATIC
Embolism
Thrombosis
CHRONIC LIMB ISCHEMIA
• Patients with chronic ischemia rest pain > 2 weeks , ulcers or gangrene attributable to objectively
proven arterial occlusive disease
• Features :
•
INVESTIGATIONS
DIAGNOSTIC TOOLS
NON
INVASIV
INVASIV
E E
Doppler’s
ABSI PPG DUPLEX ANGIOGRAM
USG
1. USG DOPPLER
• Used to identify an arterial waveform
• Normal sound is triphasic
• ARTERY: loud and sharp, rhythmic and synchronised with heartbeat
• VEIN: Low pitched, almost harsh tone (windstorm)
2. ANKLE BRACHIAL SYSTOLIC INDEX
Toe pressures use an infrared PPG sensor to determine the small vessel vascular
condition distal to the ankle.
Toe pressures may be useful in cases of unsuspected vascular disease and in baseline
diabetic foot assessment where falsely high ankle pressures can occur due to
calcification.
Interpreting the Results of a Toe Brachial Index (TBI)
The TBI is calculated by dividing the toe pressure by the highest arm pressure.
When calculating the TBI ratio use the highest arm pressure to rule out subclavean steal
syndrome.
A toe pressure of greater than 30 mmHg may be an indicator of healing potential in foot ulcer.
A PPG waveform that does not have swift recovery may indicate poor perfusion
4. SKIN PERFUSION PRESSURE
Non-invasive test.
Proved useful in the assessment of peripheral arterial disease (PAD) for both critical limb
ischaemia (CLI)
Useful in situations where toe blood pressure measurements are not possible, due to toe
amputation, ulceration or gangrene.
• CT scan + contrast
• Less invasive compared to DSA
• Use of contrast: Renal damage
7. DIGITAL SUBSTRACTION ANGIOGRAM
• Gold standard
• Invasive
• Only done if there’s potential therapeutic intervention
HOW TO CLASSIFY WHETHER IT IS VIABLE/
THREATENED/ NON-VIABLE?
INITIAL MANAGEMENT
1. HEPARIN THERAPY
• Initial bolus: 5000 unit
• Then continue with IVI heparin
• Adjust dose according to APTT ratio
• Aim: 2-3
2. Analgesics
DEFINITIVE MANAGEMENT
EMBOLISM
• Conservative Mx: Anti- coagulation only
THROMBOSIS • Thrombolytic therapy: Streptokinase, urokinase
•Conservative Mx:procedure:
Endovascular Anti- coagulation
Balloononly
catheter • Endovascular procedure: Thrombectomy,
embolectomy Angioplasty/ stents
• Arterial bypass • Arterial bypass
• Amputation • Amputation
EMBOLECTOMY
• Fogarty balloon catheter
• Insert catheter through
arteriotomy
• Clamp proximal and distal to
clot
• Catheter inserted till distal part
of clot, balloon inflated to
trawl clot out
STENTING
ARTERIAL BYPASS
• Considered when cannot be treated by
angioplasty
• Long lesion/ complete occlusion
1. REPERFUSION INJURY
• Formation of oxygen free radicals directly damage tissue & impairs adequate nutrient flow,
pr ol on gs ischaemic interval
2. RHABDOMYOLYSIS
• Release by-products of ischaemic muscles
• Electrolytes and pH change arrythmia
• Myogobulin A K I
3. COMPARTMENT SYNDROME
• Cell mb damaage and leakage of fluid into interstitium
• Four compartment fasciotomy should be performed
Risk Factor Modification:
- Cessation of Smoking
- Well control of diabetes and hypertension
- Statin therapy for hyperlipidemia
- Encourage exercise / rehabilitation
programme
DIFFERENTIAL DIAGNOSIS